<p>OVCAR-3 and OVCAR-3-TR cells were treated with ethanol vehicle or BPR0L075 (10–100 nM) for 24 hours or 10 nM BPR0L075 for indicated durations (0–48 hours), stained with propidium iodide, and analyzed by flow cytometer. The cell cycle profiles are presented as three-dimensional overlay. The X-axis shows the intensity of propidium iodide fluorescence, which indicates cellular DNA content in different cell cycle phases. The Y-axis represents the cell counts; and z-axis shows the concentration or time points of BPR0L075 treatment. 2N, cells residing in the G0–G1 phase of cell cycle; 4N, cells in the G2 phase or mitosis. BPR0L075 induces significant G2/M arrest followed by appearance of a sub-G1 population in both parental and resistant cells...
<p>(A) Flow cytometric analyses of synchronized PC3 or LNCaP cells treated by paclitaxel through the...
Background: Regulators of cell cycle phase transitions could be important targets for cancer treatme...
<p>BxPC-3 cells were treated with vehicle control, 100nM free paclitaxel, 15ug/mL α-CEA-PTX, or 15ug...
Paclitaxel plays a major role in the treatment of ovarian cancer; however, resistance to paclitaxel ...
<p>(A) Proliferating human ovarian cancer cells (SKOV-3, OVCAR-3, and A2780-1A9) and paclitaxel-resi...
<p>Western blot analysis of the PARP, caspase-2, and caspase-3 after BPR0L075 (10–100 nM) treatment ...
Paclitaxel plays a major role in the treatment of ovarian cancer; however, resistance to paclitaxel ...
[[abstract]]Paclitaxel plays a major role in the treatment of ovarian cancer; however, resistance to...
[[abstract]]Paclitaxel plays a major role in the treatment of ovarian cancer; however, resistance to...
<div><p>Paclitaxel plays a major role in the treatment of ovarian cancer; however, resistance to pac...
<p>BPR0L075 treatment (10–100 nM for 24 hours) induced changes in cyclin B1, BubR1, MPM-2, and survi...
The cytotoxicity of Cisplatin (CDDP) is traditionally believed to be cell cycle independent. This ge...
Paclitaxel is a frontline drug for the treatment of epithelial ovarian cancer (EOC). However, follow...
<p>A: CDDP (0–10 µM, 24 h) induced apoptosis in chemo-sensitive OV2008 and A2780s but not their resi...
Paclitaxel is a frontline drug for the treatment of epithelial ovarian cancer (EOC). However, follow...
<p>(A) Flow cytometric analyses of synchronized PC3 or LNCaP cells treated by paclitaxel through the...
Background: Regulators of cell cycle phase transitions could be important targets for cancer treatme...
<p>BxPC-3 cells were treated with vehicle control, 100nM free paclitaxel, 15ug/mL α-CEA-PTX, or 15ug...
Paclitaxel plays a major role in the treatment of ovarian cancer; however, resistance to paclitaxel ...
<p>(A) Proliferating human ovarian cancer cells (SKOV-3, OVCAR-3, and A2780-1A9) and paclitaxel-resi...
<p>Western blot analysis of the PARP, caspase-2, and caspase-3 after BPR0L075 (10–100 nM) treatment ...
Paclitaxel plays a major role in the treatment of ovarian cancer; however, resistance to paclitaxel ...
[[abstract]]Paclitaxel plays a major role in the treatment of ovarian cancer; however, resistance to...
[[abstract]]Paclitaxel plays a major role in the treatment of ovarian cancer; however, resistance to...
<div><p>Paclitaxel plays a major role in the treatment of ovarian cancer; however, resistance to pac...
<p>BPR0L075 treatment (10–100 nM for 24 hours) induced changes in cyclin B1, BubR1, MPM-2, and survi...
The cytotoxicity of Cisplatin (CDDP) is traditionally believed to be cell cycle independent. This ge...
Paclitaxel is a frontline drug for the treatment of epithelial ovarian cancer (EOC). However, follow...
<p>A: CDDP (0–10 µM, 24 h) induced apoptosis in chemo-sensitive OV2008 and A2780s but not their resi...
Paclitaxel is a frontline drug for the treatment of epithelial ovarian cancer (EOC). However, follow...
<p>(A) Flow cytometric analyses of synchronized PC3 or LNCaP cells treated by paclitaxel through the...
Background: Regulators of cell cycle phase transitions could be important targets for cancer treatme...
<p>BxPC-3 cells were treated with vehicle control, 100nM free paclitaxel, 15ug/mL α-CEA-PTX, or 15ug...